Thus, the presence of CRLF2 translocation and/or IKZF1 deletion makes the increased activity of the PI3K/AKT/mTOR pathway a prominent feature of B-ALL in Hispanic/Latino children, and mTOR an attractive target for treatment of this disease. This evidence concerns the gene MTOR and precursor B-cell acute lymphoblastic leukemia.